Umoja Biopharma

OverviewSuggest Edit

Umoja Biopharma is a company engaged in immunotherapies discovery. It develops an integrated healthcare technology platform for tumor treatment.
TypePrivate
Founded2019
HQSeattle, WA, US
Websiteumoja-biopharma.com

Latest Updates

Employees (est.) (Oct 2021)99(+9%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Umoja Biopharma Office Locations

Umoja Biopharma has an office in Seattle
Seattle, WA, US (HQ)
1920 Terry Ave
Seattle, WA, US
454 N 34th St
Show all (2)

Umoja Biopharma Financials and Metrics

Summary Metrics

Founding Date

2019

Umoja Biopharma total Funding

$263 m

Umoja Biopharma latest funding size

$210 m

Time since last funding

4 months ago

Umoja Biopharma investors

Umoja Biopharma's latest funding round in June 2021 was reported to be $210 m. In total, Umoja Biopharma has raised $263 m
Show all financial metrics

Umoja Biopharma Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Umoja Biopharma Online and Social Media Presence

Embed Graph

Umoja Biopharma News and Updates

CRB joins Umoja Biopharma to Celebrate the Beginning of Construction at Development and Manufacturing Site

LOUISVILLE, Colo., Aug. 31, 2021 /PRNewswire/ -- On Monday, August 30, Umoja Biopharma and CRB officially kicked off the construction of a 146,000 square foot development and clinical manufacturing facility. CRB, an international leader in sustainable engineering, architecture,...

Umoja Biopharma Appoints Greg Sargen to its Board of Directors

SEATTLE, Aug. 24, 2021 /PRNewswire/ -- Umoja Biopharma, an oncology company leveraging its proprietary integrated technologies to reprogram immune cells in vivo to create next-generation immunotherapies for the treatment of solid tumors and hematologic malignancies, today announced the...

Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development

SEATTLE, July 27, 2021 /PRNewswire/ -- Umoja Biopharma, an oncology company leveraging its proprietary integrated technologies to reprogram immune cells in vivo to create next-generation immunotherapies for the treatment of solid tumors and hematologic malignancies, today announced the...

Umoja Biopharma Launches with $53M Series A Financing to Develop Fully Integrated, Scalable, In Vivo Immunotherapy Platform

SEATTLE, Nov. 18, 2020 /PRNewswire/ -- Umoja Biopharma, a biotechnology company pioneering an integrated in vivo immunotherapy platform, today announced the completion of its $53 million Series A financing led by MPM Capital and Qiming Venture Partners USA. Umoja was founded by a team of...

Umoja Biopharma Frequently Asked Questions

  • When was Umoja Biopharma founded?

    Umoja Biopharma was founded in 2019.

  • How many employees does Umoja Biopharma have?

    Umoja Biopharma has 99 employees.

  • Who are Umoja Biopharma competitors?

    Competitors of Umoja Biopharma include Aprogen, Bioceros and Frontier Medicines.

  • Where is Umoja Biopharma headquarters?

    Umoja Biopharma headquarters is located at 1920 Terry Ave, Seattle.

  • Where are Umoja Biopharma offices?

    Umoja Biopharma has an office in Seattle.

  • How many offices does Umoja Biopharma have?

    Umoja Biopharma has 2 offices.